Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of 25.41% is 74% above its 5-year average of 14.61%, near the high end of its 5-year range (0.58%–25.79%).
As of the fiscal period ended Tuesday, June 30, 2026. 3.70% above its 12-month average of 24.51%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): 25.41%.
RETURN ON EQUITY (ROE)
25.41%
RETURN ON EQUITY (ROE) AVG TTM
24.51%
RETURN ON EQUITY (ROE) AVG 3Y
13.08%
RETURN ON EQUITY (ROE) AVG 5Y
14.61%
RETURN ON EQUITY (ROE) AVG 10Y
8.56%
RETURN ON EQUITY (ROE) AVG 15Y
9.10%
RETURN ON EQUITY (ROE) AVG 20Y
9.10%
CURRENT VS TTM AVG
+3.70%
CURRENT VS 3Y AVG
+94.33%
CURRENT VS 5Y AVG
+74.00%
CURRENT VS 10Y AVG
+196.93%
CURRENT VS 15Y AVG
+179.35%
CURRENT VS 20Y AVG
+179.35%
SECTOR MEDIAN · HEALTHCARE
13.01%
median of 84 covered companies
CURRENT VS SECTOR MEDIAN
+95.34%
vs the sector median at left
Incyte Corporation
Market Cap
$25.40B
Return on Equity (ROE)
25.41%
TTM Avg
24.51%
3Y Avg
13.08%
5Y Avg
14.61%
Market Cap
$25.49B
Return on Equity (ROE)
18.89%
TTM Avg
16.95%
3Y Avg
19.08%
5Y Avg
20.56%
Market Cap
$26.30B
Return on Equity (ROE)
11.65%
TTM Avg
9.71%
3Y Avg
9.35%
5Y Avg
12.84%
Market Cap
$24.13B
Return on Equity (ROE)
-9.62%
TTM Avg
-4.55%
3Y Avg
10.63%
5Y Avg
21.70%
Market Cap
$26.75B
Return on Equity (ROE)
5.97%
TTM Avg
9.02%
3Y Avg
4.86%
5Y Avg
4.86%
Market Cap
$27.20B
Return on Equity (ROE)
14.13%
TTM Avg
13.34%
3Y Avg
14.07%
5Y Avg
18.07%
Market Cap
$28.14B
Return on Equity (ROE)
7062.40%
TTM Avg
-2178.82%
3Y Avg
-341.14%
5Y Avg
-117.12%
Market Cap
$28.97B
Return on Equity (ROE)
14.51%
TTM Avg
21.84%
3Y Avg
21.53%
5Y Avg
32.27%
Market Cap
$21.00B
Return on Equity (ROE)
20.48%
TTM Avg
18.68%
3Y Avg
17.25%
5Y Avg
16.03%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Incyte Corporation (INCY) | $25.40B | 25.41% | 24.51% | 13.08% | 14.61% |
| West Pharmaceutical Services, Inc. (WST)vs › | $25.49B | 18.89% | 16.95% | 19.08% | 20.56% |
| Labcorp Holdings Inc. (LH)vs › | $26.30B | 11.65% | 9.71% | 9.35% | 12.84% |
| BioNTech SE (BNTX)vs › | $24.13B | -9.62% | -4.55% | 10.63% | 21.70% |
| Medline Inc. (MDLN)vs › | $26.75B | 5.97% | 9.02% | 4.86% | 4.86% |
| Quest Diagnostics Incorporated (DGX)vs › | $27.20B | 14.13% | 13.34% | 14.07% | 18.07% |
| Mettler-Toledo International Inc. (MTD)vs › | $28.14B | 7062.40% | -2178.82% | -341.14% | -117.12% |
| GE HealthCare Technologies Inc. (GEHC)vs › | $28.97B | 14.51% | 21.84% | 21.53% | 32.27% |
| United Therapeutics Corporation (UTHR)vs › | $21.00B | 20.48% | 18.68% | 17.25% | 16.03% |
| Zoetis Inc. (ZTS)vs › | $29.95B | 83.10% | 66.19% | 56.82% | 52.60% |
ROE
25.4%
ROA
20.5%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | 25.41% |
| 2026-03-31 | 25.79% |
| 2025-12-31 | 24.90% |
| 2025-09-30 | 25.55% |
| 2025-06-30 | 20.88% |
| 2025-03-31 | 0.58% |
| 2024-12-31 | 0.95% |
| 2024-09-30 | 1.02% |
| 2024-06-30 | 3.25% |
| 2024-03-31 | 13.82% |
| 2023-12-31 | 11.51% |
| 2023-09-30 | 8.62% |
| 2023-06-30 | 7.73% |
| 2023-03-31 | 7.27% |
| 2022-12-31 | 7.80% |
| 2022-09-30 | 20.73% |
| 2022-06-30 | 23.13% |
| 2022-03-31 | 24.15% |
| 2021-12-31 | 25.16% |
| 2021-09-30 | 16.98% |
| 2021-06-30 | 11.50% |
| 2021-03-31 | 17.54% |
| 2020-12-31 | -11.32% |
| 2020-09-30 | -13.99% |
| 2020-06-30 | -8.15% |
| 2020-03-31 | -19.41% |
| 2019-12-31 | 17.20% |
| 2019-09-30 | 16.72% |
| 2019-06-30 | 13.61% |
| 2019-03-31 | 12.13% |
| 2018-12-31 | 5.69% |
| 2018-09-30 | -6.06% |
| 2018-06-30 | -5.90% |
| 2018-03-31 | -10.27% |
| 2017-12-31 | -19.20% |
| 2017-09-30 | -8.80% |
| 2017-06-30 | -14.98% |
| 2017-03-31 | -11.07% |
| 2016-12-31 | 24.85% |
| 2016-09-30 | 40.68% |
| 2016-06-30 | 24.93% |
| 2016-03-31 | 21.49% |
| 2015-12-31 | 3.81% |
| 2015-09-30 | -96.45% |
| 2015-06-30 | 24.08% |
| 2013-09-30 | -74.67% |
| 2005-06-30 | -322.30% |
| 2005-03-31 | -245.93% |
| 2004-12-31 | -209.91% |
| 2004-09-30 | -546.35% |
| 2004-06-30 | -351.68% |
| 2004-03-31 | -125.95% |
| 2003-12-31 | -107.86% |
| 2003-09-30 | -99.55% |
| 2003-06-30 | -79.45% |
